HealthEquity 미래 성장

Future 기준 확인 4/6

HealthEquity (는) 각각 연간 39.8% 및 10.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 39.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 13.5% 로 예상됩니다.

주요 정보

39.8%

수익 성장률

39.1%

EPS 성장률

Healthcare 수익 성장	20.8%
매출 성장률	10.1%
향후 자기자본 수익률	13.5%
애널리스트 커버리지	Good
마지막 업데이트	19 Dec 2024

최근 미래 성장 업데이트

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jun 07

Recent updates

HealthEquity's (NASDAQ:HQY) Returns On Capital Not Reflecting Well On The Business

Dec 04

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate

Nov 20

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Jun 21

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jun 07

HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore

Jun 04

HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind

May 29

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

May 03

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

Apr 11

HealthEquity: Multiple Compression Has Finally Made It A Buy

Mar 21

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Dec 28

HealthEquity Non-GAAP EPS of $0.33 in-line, revenue of $206.1M beats by $2.22M

Sep 06

HealthEquity: Asymmetry In Valuation Continues To Widen

Aug 25

HealthEquity COO steps down, CEO to assume his responsibilities

Aug 02

수익 및 매출 성장 예측

NasdaqGS:HQY - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
1/31/2027	1,453	227	469	505	9
1/31/2026	1,294	157	402	424	12
1/31/2025	1,192	101	295	307	13
10/31/2024	1,150	97	-162	341	N/A
7/31/2024	1,099	106	-198	308	N/A
4/30/2024	1,043	80	-30	277	N/A
1/31/2024	1,000	56	197	243	N/A
10/31/2023	971	29	176	221	N/A
7/31/2023	938	13	169	212	N/A
4/30/2023	901	-8	121	175	N/A
1/31/2023	862	-26	32	151	N/A
10/31/2022	831	-59	21	146	N/A
7/31/2022	795	-62	-71	120	N/A
4/30/2022	778	-55	-76	117	N/A
1/31/2022	757	-44	4	141	N/A
10/31/2021	741	-6	10	151	N/A
7/31/2021	741	1	99	181	N/A
4/30/2021	728	4	108	198	N/A
1/31/2021	734	9	85	182	N/A
10/31/2020	747	3	64	152	N/A
7/31/2020	724	-20	34	117	N/A
4/30/2020	635	0	35	95	N/A
1/31/2020	532	40	63	105	N/A
10/31/2019	407	53	72	107	N/A
7/31/2019	320	90	96	118	N/A
4/30/2019	304	93	96	116	N/A
1/31/2019	287	74	98	113	N/A
10/31/2018	272	67	82	101	N/A
7/31/2018	258	61	N/A	95	N/A
4/30/2018	244	56	N/A	89	N/A
1/31/2018	230	47	N/A	82	N/A
10/31/2017	216	46	N/A	76	N/A
7/31/2017	202	41	N/A	70	N/A
4/30/2017	190	32	N/A	59	N/A
1/31/2017	178	26	N/A	46	N/A
10/31/2016	167	25	N/A	39	N/A
7/31/2016	155	24	N/A	35	N/A
4/30/2016	141	20	N/A	27	N/A
1/31/2016	127	17	N/A	27	N/A
10/31/2015	116	15	N/A	23	N/A
7/31/2015	107	14	N/A	17	N/A
4/30/2015	97	13	N/A	15	N/A
1/31/2015	88	12	N/A	15	N/A
10/31/2014	80	1	N/A	16	N/A
7/31/2014	74	-1	N/A	16	N/A
4/30/2014	68	-4	N/A	16	N/A
1/31/2014	62	-7	N/A	18	N/A

애널리스트 미래 성장 예측

수입 대 저축률: HQY 의 연간 예상 수익 증가율( 39.8% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: HQY 의 연간 수익( 39.8% ) US 시장( 15.2% 보다 빠르게 성장할 것으로 예상됩니다. 15.2% 연간).

고성장 수익: HQY 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: HQY 의 수익(연간 10.1% ) US 시장( 9.1% 보다 빠르게 성장할 것으로 예상됩니다. 9.1% 연간).

고성장 수익: HQY 의 수익(연간 10.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: HQY 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 13.5 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/22 09:09
장 마감 주가	2024/12/20 00:00
수익	2024/10/31
연간 수익	2024/01/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

HealthEquity, Inc. 24 애널리스트 중 13 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Mark Marcon	Baird
Ishan Majumdar	Baptista Research
Alexander Paris	Barrington Research Associates, Inc.

HealthEquity 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 10%

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025 and Fiscal Year Ending January 31, 2026

Consensus EPS estimates increase by 15%

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025

Consensus EPS estimates increase by 19%

Recent updates

Consensus EPS estimates fall by 10%

Independent Director recently sold US$2.4m worth of stock

New minor risk - Earnings quality

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025 and Fiscal Year Ending January 31, 2026

HealthEquity's (NASDAQ:HQY) Returns On Capital Not Reflecting Well On The Business

HealthEquity, Inc. and WageWorks, Inc. Settle Their Lawsuit with Union Mesa 1, LLC

HealthEquity, Inc. and WageWorks, Inc. Settle Their Lawsuit with Union Mesa 1, LLC

HealthEquity, Inc. (NASDAQ:HQY) Shares Could Be 41% Below Their Intrinsic Value Estimate

HealthEquity: High Marks For Recent Profit Growth

HealthEquity, Inc. Announces CEO Changes, Effective January 6, 2025

We Think HealthEquity (NASDAQ:HQY) Can Stay On Top Of Its Debt

HealthEquity, Inc. to Report Q3, 2025 Results on Dec 09, 2024

HealthEquity, Inc Launches HSAnswers

Independent Non-Executive Chairman notifies of intention to sell stock

HealthEquity, Inc Launches HSAnswers

Executive VP & CTO recently sold US$947k worth of stock

Independent Director notifies of intention to sell stock

HealthEquity, Inc. (NasdaqGS:HQY) announces an Equity Buyback for $300 million worth of its shares.

Getting In Cheap On HealthEquity, Inc. (NASDAQ:HQY) Might Be Difficult

HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy

HealthEquity, Inc. to Report Q2, 2025 Results on Sep 03, 2024

Founder & Vice Chairman exercised options and sold US$2.3m worth of stock

Is HealthEquity (NASDAQ:HQY) Using Too Much Debt?

President notifies of intention to sell stock

We Think Some Shareholders May Hesitate To Increase HealthEquity, Inc.'s (NASDAQ:HQY) CEO Compensation

Consensus EPS estimates increase by 15%

Founder & Vice Chairman notifies of intention to sell stock

Earnings Beat: HealthEquity, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2025

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore

HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind

HealthEquity, Inc. to Report Q1, 2025 Results on Jun 03, 2024

Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 48%?

HealthEquity, Inc., Annual General Meeting, Jun 27, 2024

Market Participants Recognise HealthEquity, Inc.'s (NASDAQ:HQY) Revenues

President notifies of intention to sell stock

HealthEquity: Multiple Compression Has Finally Made It A Buy

Full year 2024 earnings: EPS exceeds analyst expectations

HealthEquity, Inc. to Report Q4, 2024 Results on Mar 19, 2024

Consensus EPS estimates increase by 19%

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Fiscal Year Ending January 31, 2025

Investors Appear Satisfied With HealthEquity, Inc.'s (NASDAQ:HQY) Prospects

Consensus EPS estimates increase by 39%

Founder & Vice Chairman notifies of intention to sell stock

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025

HealthEquity, Inc. to Report Q3, 2024 Results on Dec 05, 2023

President notifies of intention to sell stock

HealthEquity, Inc. (NasdaqGS:HQY) entered into a definitive agreement to acquire BenefitWallet’s Health Savings Account (HSA) portfolio from Conduent Business Services, LLC for $425 million.

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. to Report Q2, 2024 Results on Sep 05, 2023

HealthEquity, Inc. Announces the Termination of the Employment of Larry Trittschuh, Executive Vice President and Chief Security Officer

President notifies of intention to sell stock

Executive VP & CTO recently sold US$653k worth of stock

HealthEquity, Inc. Announces Change of CFO

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. Provides Earnings Guidance for the Year Ending January 31, 2024

HealthEquity, Inc. to Report Q1, 2024 Results on Jun 05, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Independent Director recently sold US$325k worth of stock

HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023 and January 31, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

HealthEquity, Inc. to Report Q3, 2023 Results on Dec 06, 2022

Executive VP notifies of intention to sell stock

Executive VP & Chief Security Officer exercised options and sold US$67k worth of stock

Independent Director recently sold US$300k worth of stock

Independent Director recently sold US$1.8m worth of stock